Weekly Intelligence · 13 articles

Vet Industry Intel: Aug 16 – Aug 22, 2026

High-signal veterinary industry stories triangulated from multiple sources, scored for relevance, and grouped by event type.

Funding & Investment (2) Leadership Changes (1) Regulatory & Policy (9) Industry News (1)

Funding & Investment

Aug 19, 2026 [9/10] MarketBeat

Mitsubishi UFJ Asset Management Co. Ltd. Has $76.91 Million Stake in Zoetis Inc. $ZTS

Mitsubishi UFJ Asset Management Co. Ltd. acquired a $76.91 million stake in Zoetis Inc., a major veterinary pharmaceutical company.

Mitsubishi UFJ Asset Management Co. Ltd. · Zoetis Inc. | NJ

Aug 19, 2026 [9/10] The Business Journals

Charlotte vet startup Petfolk closes $40M funding round

Petfolk, a veterinary practice management software startup based in Charlotte, raised $40 million in a funding round.

Petfolk · The Business Journals | NC

Leadership Changes

Aug 17, 2026 [9/10] The Healthcare Technology Report.

GE HealthCare CFO Jay Saccaro Leaves for Expanded Role at Zoetis

GE HealthCare CFO Jay Saccaro has left his position to take an expanded role at Zoetis, a major veterinary pharmaceutical company.

GE HealthCare · Zoetis · The Healthcare Technology Report

Regulatory & Policy

Aug 17, 2026 [10/10] MyChesCo

FDA Authorizes Simparica TRIO for Screwworm in Dogs

The U.S. Food and Drug Administration has approved Simparica TRIO for the treatment of screwworm infestation in dogs.

FDA · Simparica TRIO

Aug 22, 2026 [9/10] Gulf Coast Media

FDA authorizes Simparica TRIO for emergency treatment of New World screwworm in dogs

The FDA has authorized the use of Simparica TRIO for emergency treatment of New World screwworm infestations in dogs.

FDA · Gulf Coast Media

Aug 18, 2026 [9/10] simplywall.st

How Investors Are Reacting To Zoetis (ZTS) Cut Guidance Flat Q2 Results And New FDA EUA

Zoetis announced a flat Q2 earnings outlook and received a new FDA Emergency Use Authorization, prompting investor reactions.

Zoetis · FDA

Aug 22, 2026 [9/10] Gulf Coast Media

FDA authorizes Simparica TRIO for emergency treatment of New World screwworm in dogs

The U.S. Food and Drug Administration has authorized the use of Simparica TRIO for emergency treatment of New World screwworm infestations in dogs.

FDA · Zoetis

Aug 20, 2026 [9/10] Newsweek

FDA Authorizes Emergency Drug To Help Treat New World Screwworm in Dogs

The U.S. Food and Drug Administration has authorized an emergency drug to treat New World Screwworm infestations in dogs.

FDA

Aug 22, 2026 [9/10]

Purina Pro Plan Veterinary Diets El Elemental Recall 2023 FDA - View UmtTCYm3m - SECOVI-SP

Purina Pro Plan Veterinary Diets recalled the El Elemental product in 2023 following FDA action.

Purina Pro Plan Veterinary Diets · FDA

Aug 17, 2026 [9/10] Baltimore Sun

FDA approves an emergency drug for New World screwworm infestation in dogs

The U.S. Food and Drug Administration has approved an emergency drug to treat New World screwworm infestation in dogs.

FDA | MD

Aug 18, 2026 [9/10] simplywall.st

How Investors Are Reacting To Zoetis (ZTS) Cut Guidance Flat Q2 Results And New FDA EUA

Zoetis announced a flat Q2 earnings outlook and received a new FDA Emergency Use Authorization, prompting investor reactions.

Zoetis · FDA · simplywall.st

Aug 22, 2026 [9/10] Gulf Coast Media

FDA authorizes Simparica TRIO for emergency treatment of New World screwworm in dogs

The U.S. Food and Drug Administration has authorized the use of Simparica TRIO for emergency treatment of New World screwworm infestations in dogs.

FDA

Industry News

Aug 18, 2026 [8/10] Seeking Alpha

IDEXX Labs Executing, But Valuation Continues To Weigh On That Execution (NASDAQ:IDXX)

IDEXX Labs reports ongoing execution challenges, with valuation pressures impacting its performance.

IDEXX Labs

Most-mentioned this week

Zoetis (1)